Correlation Between GomSpace Group and Hansa Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GomSpace Group and Hansa Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GomSpace Group and Hansa Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GomSpace Group AB and Hansa Biopharma AB, you can compare the effects of market volatilities on GomSpace Group and Hansa Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GomSpace Group with a short position of Hansa Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of GomSpace Group and Hansa Biopharma.

Diversification Opportunities for GomSpace Group and Hansa Biopharma

0.78
  Correlation Coefficient

Poor diversification

The 3 months correlation between GomSpace and Hansa is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding GomSpace Group AB and Hansa Biopharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hansa Biopharma AB and GomSpace Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GomSpace Group AB are associated (or correlated) with Hansa Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hansa Biopharma AB has no effect on the direction of GomSpace Group i.e., GomSpace Group and Hansa Biopharma go up and down completely randomly.

Pair Corralation between GomSpace Group and Hansa Biopharma

Assuming the 90 days trading horizon GomSpace Group AB is expected to generate 1.03 times more return on investment than Hansa Biopharma. However, GomSpace Group is 1.03 times more volatile than Hansa Biopharma AB. It trades about 0.26 of its potential returns per unit of risk. Hansa Biopharma AB is currently generating about -0.27 per unit of risk. If you would invest  378.00  in GomSpace Group AB on August 29, 2024 and sell it today you would earn a total of  79.00  from holding GomSpace Group AB or generate 20.9% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

GomSpace Group AB  vs.  Hansa Biopharma AB

 Performance 
       Timeline  
GomSpace Group AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GomSpace Group AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Hansa Biopharma AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hansa Biopharma AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

GomSpace Group and Hansa Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GomSpace Group and Hansa Biopharma

The main advantage of trading using opposite GomSpace Group and Hansa Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GomSpace Group position performs unexpectedly, Hansa Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hansa Biopharma will offset losses from the drop in Hansa Biopharma's long position.
The idea behind GomSpace Group AB and Hansa Biopharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Stocks Directory
Find actively traded stocks across global markets